{"publication_id":"f1b39b71-2cc3-43a3-ab5a-287574699c7d","method_note":"Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.","sources":[{"study":"Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer","doi":"10.1186/s12885-023-10631-w","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials","doi":"10.1016/j.athplu.2024.10.001","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Reno-protective effects of statins among patients with chronic kidney disease in Hong Kong: a target trial emulation","doi":"10.1016/j.eclinm.2026.103798","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin","doi":"10.12997/jla.2020.9.2.283","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial","doi":"10.1016/j.ibneur.2024.07.002","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study","doi":"10.1371/journal.pone.0286670","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial","doi":"10.1371/journal.pone.0278282","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"The effect of rosuvastatin alone or in combination with fenofibrate or omega-3 fatty acids on lipoprotein(a) levels in patients with mixed hyperlipidemia","doi":"10.5114/amsad/178441","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol","doi":"10.3389/fphys.2021.750872","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention","doi":"10.1371/journal.pone.0311724","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis","doi":"10.3389/fmed.2021.769740","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients – A Register Study in Finland before COVID-19 Vaccines","doi":"10.1177/21501319261453019","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Abstract 12870: Absence of LDL Measurement in Secondary Prevention is Associated With Increased Subsequent Major Adverse Clinical Event (MACE) That is Only Partially Mitigated by Statin Use","doi":"10.1161/circ.146.suppl_1.12870","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"APOEGenotype and Statin Response: Evidence from Electronic Health Records in the UK Biobank and All of Us Research Program","doi":"10.1101/2024.12.13.24318985","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Understanding the causes and consequences of low statin adherence: evidence from UK Biobank primary care data","doi":"10.1101/2025.01.23.25321011","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"HMG-CoA reductase inhibitors and the attenuation of risk for disseminated intravascular coagulation in patients with sepsis: Secondary analysis finds no change in the index outcome based on reason for statin prescription","doi":"10.1182/blood-2025-1309","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Estimating prevalence and characteristics of statin intolerance among high and very high cardiovascular risk patients in Germany between 2017–2020","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effect of Simvastatin Withdrawal on Ocular Endothelial Function","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"STATIC - Statin Termination in Cancer","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"APOE Genotype and Statin Response: Evidence from the UK Biobank Baseline Assessment and Linked Mortality Data","doi":"10.1101/2024.12.13.24318982","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of statin treatment on primary and hospital care use: a microsimulation model","doi":"10.1101/2025.09.30.25337016","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"The Effects of Rosuvastatin on Running Training Adaptation and Safety","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"A randomised clinical trial of STAtin therapy for Reducing Events in the Elderly (STAREE): Statistical analysis plan","doi":"10.1101/2025.02.24.25321974","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Clinical validation of a statin-benefit polygenic score using real-world cohorts of primary prevention participants","doi":"10.1101/2025.10.09.25337698","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Statin Reminders for Improving Prescribing in Primary Care","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of Atorvastatin in Graves' Orbitopathy (GO)","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Pravastatin to Prevent Preeclampsia","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"A prospective study of hepatic safety of statins used in very elderly patients","doi":"10.1186/s12877-019-1361-2","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Statins Against Bushfire Smoke","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"MUscle Side-Effects of Atorvastatin in Coronary Patients","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Evaluation of Rosuvastatin Effect as Adjuvant Therapy to Methotrexate on Lipid Profile and the Possibility of its Cardioprotective Effect in Iraqi Patients with Active Rheumatoid Arthritis","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Simvastatin Addition for Patients With Recent-onset Schizophrenia","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Does Rosuvastatin Delay Progression of Atherosclerosis in HIV","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Efficacy and Safety of Atorvastatin 2025","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Effects of Statin for Elderly 2023","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Evolocumab Plus Ezetimibe 2020","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"TRIal of STatin Therapy n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Multicenter Study to Evaluate 2023","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Efficacy and Safety of Early 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Estimating Prevalence and Characteristics 2022","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Statins Against Bushfire n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Relationship between Insulin Resistance 2020","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Statin Therapy with Atorvastatin n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Week Phase Study 2017","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Effect of Simvastatin Withdrawal 2020","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"MUscle Side-Effects of Atorvastatin 2019","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Statin TReatment for COVID 2025","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"PCOS 2017","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Envafolimab with Chemotherapy and Simvastatin 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Evaluation of Rosuvastatin Effect 2017","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Randomized Comparison of Efficacy 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"STATIC Statin Termination 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Atorvastatin for Reduction of Day 2021","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Changes in Plaque Characteristics 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Effect of Pravastatin in the Subjects 2017","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Evaluate the Efficacy and Safety 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"MACE 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Rosuvastatin for Prevention of Anthracycline-induced n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Simvastatin Addition for Patients 2019","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Statin Monotherapy or Statins 2021","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"APICES n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Carvedilol Simvastatin vs Carvedilol n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Comparison of Pitavastatin Plus n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Does Rosuvastatin Delay 2018","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Effects of Atorvastatin in Graves' 2021","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Intermediate-dose vs Standard Prophylactic 2021","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Moderate-intensity Statin vs Individualized n.d.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Pravastatin Intervention to Delay 2018","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Pravastatin to Prevent Preeclampsia 2021","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Statin Monotherapy for Treatment 2022","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Statin Reminders for Improving 2024","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"StAtins for Venous Event 2020","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Effects of Rosuvastatin on Running 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Ursodeoxycholic Acid Attenuates 2026","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"}]}